Literature DB >> 34484900

Health-Related Quality of Life May Predict Disease Staging in 10 Years in Parkinson Disease With Hoehn-Yahr Stage III.

Hiroshi Kataoka1, Kazuma Sugie1.   

Abstract

BACKGROUND: Ten years ago, we examined 30 patients with Hoehn-Yahr stage III Parkinson disease (PD) to determine predictors related to falling, including walking speed, step number, and step time by using the originally designed narrowed paths. We verified the increased number of steps as greater risk for an upgrade of Hoehn-Yahr stage in a 6-year period. We further prospectively studied the same patients whether the step number on a sudden narrow path persists as a predictor of the severity of PD.
METHODS: The follow-up patients were divided into 2 groups-patients with and without an increase in Hoehn-Yahr stage. Variables with a significant relation to the development of Hoehn-Yahr stage on a single variable logistic regression analysis (p < 0.05) were entered into multiple logistic regression analysis, adjusting both age and disease duration.
RESULTS: The significant variables between patients with and without an increase in Hoehn-Yahr stage were 36-item Short-Form Health Survey (SF-36) scores at 2, 4, 6, and 8 years. Multiple logistic regression analyses after adjusting both age and disease duration showed the SF-36 score at 2, 4, 6, and 8 years. The domain in social functioning significantly differed between patients with and without deterioration of Hoehn-Yahr stage in 10 years.
CONCLUSIONS: This study demonstrated the capacity of low health-related quality of life (HR-QOL) to predict future developments of PD staging in 10 years. The lower HR-QOL, particularly in social functioning, may reflect the severity of both motor and nonmotor symptoms.
© 2021 American Academy of Neurology.

Entities:  

Year:  2021        PMID: 34484900      PMCID: PMC8382375          DOI: 10.1212/CPJ.0000000000000924

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  24 in total

1.  Low frontal assessment battery score as a risk factor for falling in patients with Hoehn-Yahr Stage III Parkinson's disease: a 2-year prospective study.

Authors:  Hiroshi Kataoka; Noriyuki Tanaka; Keigo Saeki; Takao Kiriyama; Satoshi Ueno
Journal:  Eur Neurol       Date:  2014-01-21       Impact factor: 1.710

2.  Risk of falling in Parkinson's disease at the Hoehn-Yahr stage III.

Authors:  Hiroshi Kataoka; Noriyuki Tanaka; M Eng; Keigo Saeki; Takao Kiriyama; Nobuyuki Eura; Masanori Ikeda; Tesseki Izumi; Takanori Kitauti; Yoshiko Furiya; Kazuma Sugie; Yoshito Ikada; Satoshi Ueno
Journal:  Eur Neurol       Date:  2011-11-01       Impact factor: 1.710

3.  Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.

Authors:  M Reuther; E A Spottke; J Klotsche; O Riedel; H Peter; K Berger; O Athen; R Köhne-Volland; R C Dodel
Journal:  Parkinsonism Relat Disord       Date:  2006-10-19       Impact factor: 4.891

4.  Low FAB score as a predictor of future falling in patients with Parkinson's disease: a 2.5-year prospective study.

Authors:  Hiroshi Kataoka; Satoshi Ueno
Journal:  J Neurol       Date:  2015-06-17       Impact factor: 4.849

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Age and time course of long-term motor and nonmotor complications in Parkinson disease.

Authors:  Stéphane Prange; Teodor Danaila; Chloé Laurencin; Catherine Caire; Elise Metereau; Hélène Merle; Emmanuel Broussolle; Delphine Maucort-Boulch; Stéphane Thobois
Journal:  Neurology       Date:  2018-12-12       Impact factor: 9.910

7.  Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?

Authors:  A Minguez-Castellanos; F Escamilla-Sevilla; M J Katati; J M Martin-Linares; M Meersmans; A Ortega-Moreno; V Arjona
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

8.  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

Authors:  V Peto; C Jenkinson; R Fitzpatrick; R Greenhall
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

Review 9.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

10.  Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort.

Authors:  Zhaohui Qin; Liyan Zhang; Fei Sun; Xianghua Fang; Cheryl Meng; Caroline Tanner; Piu Chan
Journal:  Parkinsonism Relat Disord       Date:  2009-06-23       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.